Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. is the post-merger operating company formed through the combination with Leisure Acquisition Corp., a blank-check company that traded on Nasdaq under the ticker LACQ and completed its IPO in 2018. The SPAC was sponsored by Hydra Management LLC and targeted the healthcare sector, ultimately closing its business combination with Ensysce, a biopharmaceutical company focused on abuse-deterrent drug formulations, in mid-2021. The August 2023 8-K filing represents a routine current-report disclosure from the combined entity, which now trades under the ticker ENSC. Sign up for full data, filings history, and sponsor analytics on SpacDesk.